<DOC>
	<DOCNO>NCT00315744</DOCNO>
	<brief_summary>Asthmatic child remain symptomatic inhaled corticosteroid ( ICS ) require adjustment asthma therapy . Current guideline suggest treatment option either increase dose inhale corticosteroid addition therapy long-acting beta-agonist ( LABA ) . In paediatric age range , major concern respect high dose ICS therapy growth retardation suppression hypothalamic-pituitary-adrenocortical ( HPA ) axis . Previous study adults show combination product include LABA well ICS allow reduce steroid dose still least effective achieve asthma control treatment high dose ICS . These treatment option shall compare present study . Children remain symptomatic inhale 100 µg fluticasone ( FP ) twice daily shall randomise receive salmeterol/ fluticasone combination product , Viani ( SERETIDE ) 50/100 µg , fluticasone 200 µg comparator drug , inhaled twice daily via DISKUS period eight week .</brief_summary>
	<brief_title>Viapaed Study In Children And Adolescents With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Children age 4 16 year establish history perennial asthma . Subjects treat inhaled corticosteroid accord BDP ( budesonide ) 200400 µg/day equivalent last 4 week runin . 15 minute inhale 200µg salbutamol , reversible increase FEV1 least 12 % predose value . Willingness substitute previous controller medication twice daily inhalation fluticasone 100µg bid via DISKUS® . Subjects/guardians give write informed consent participate study . Subjects /guardians able understand complete diary record card ( DRC ) . Subjects able use MiniWright Peak Flow meter . Sexually active female adolescent must use adequate contraception . Willingness refrain controller medication ( include antileukotrienes ) regular use shortacting beta agonist anticholinergics treatment period .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>moderate asthma</keyword>
	<keyword>fluticasone</keyword>
	<keyword>child</keyword>
	<keyword>salmeterol</keyword>
	<keyword>steroid-sparing</keyword>
	<keyword>Asthma</keyword>
</DOC>